Technical analysis of None (HSDT): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma.
Price Performance
| 1 month | +29.21% |
| 3 months | +41.98% |
| Year-to-date | -20.42% |
| 1 year | -89.89% |
| 3 years | -99.96% |
| 5 years | -100.00% |
52-Week Range
| 52-week High | $25.50 |
| 52-week Low | $1.19 |
| Avg Volume (90d) | 307K |
Technical Indicators
| SMA 50 | $1.90 |
| SMA 200 | $2.23 |
| Beta | 0.91 |
| 30-day Volatility (annualised) | 86.9% |
| Price vs SMA 50 | +21.1% |
| Price vs SMA 200 | +3.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $5.94 | |
| 2025-11 | $4.15 | -30.1% |
| 2025-12 | $2.89 | -30.4% |
| 2026-01 | $2.75 | -4.8% |
| 2026-02 | $1.87 | -32.0% |
| 2026-03 | $1.73 | -7.5% |
| 2026-04 | $2.04 | +17.9% |
| 2026-05 | $1.91 | -6.4% |
| 2026-06 | $1.65 | -13.6% |
| 2026-07 | $1.65 | +0.0% |
| 2026-08 | $2.21 | +33.9% |
| 2026-09 | $2.30 | +4.1% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $2.30 |
| Market Cap | $134M |
Valuation Ratios
| Price / Book | 0.99 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 13.31 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 11.60 |